Impact of oral cyclophosphamide on healt
β
Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff
π
Article
π
2007
π
John Wiley and Sons
π
English
β 92 KB
π 2 views
## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the healthβrelated quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fiftyβeight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC